Larry Biegelsen
Stock Analyst at Wells Fargo
(3.58)
# 772
Out of 5,182 analysts
373
Total ratings
50.76%
Success rate
4.4%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMED Minimed Group | Initiates: Overweight | $26 | $13.23 | +96.52% | 1 | Mar 31, 2026 | |
| HTFL HeartFlow | Maintains: Overweight | $38 → $35 | $26.87 | +30.26% | 2 | Mar 19, 2026 | |
| AVR Anteris Technologies Global | Initiates: Overweight | $16 | $5.32 | +200.75% | 1 | Mar 11, 2026 | |
| TFX Teleflex | Maintains: Equal-Weight | $116 → $130 | $115.51 | +12.54% | 10 | Feb 27, 2026 | |
| MMSI Merit Medical Systems | Downgrades: Equal-Weight | $95 → $78 | $67.40 | +15.73% | 13 | Feb 26, 2026 | |
| ALC Alcon | Upgrades: Overweight | $88 → $97 | $74.67 | +29.90% | 10 | Feb 26, 2026 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $17 → $18 | $15.92 | +13.07% | 10 | Feb 19, 2026 | |
| AXGN Axogen | Initiates: Overweight | $40 | $30.99 | +29.07% | 1 | Feb 19, 2026 | |
| GKOS Glaukos | Maintains: Overweight | $122 → $135 | $115.06 | +17.33% | 18 | Feb 18, 2026 | |
| DXCM DexCom | Maintains: Overweight | $93 → $85 | $63.11 | +34.69% | 11 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $145 → $70 | $54.42 | +28.63% | 16 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $93 → $98 | $91.40 | +7.22% | 11 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $96 → $100 | $80.84 | +23.70% | 19 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $97 | $69.73 | +39.11% | 6 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $94 | $61.86 | +51.96% | 16 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $230 → $240 | $238.41 | +0.67% | 15 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $374 | $329.96 | +13.35% | 20 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $27 → $28 | $19.49 | +43.66% | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $72 → $82 | $69.66 | +17.71% | 20 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $114 | $86.42 | +31.91% | 19 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $452 → $456 | $332.07 | +37.32% | 17 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $14 | $18.28 | -23.41% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $10 | $6.76 | +47.93% | 16 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $599 → $600 | $452.95 | +32.46% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $0.68 → $0.85 | $1.11 | -23.42% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $3 | $1.28 | +134.38% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $16.62 | +44.40% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $10.35 | +40.10% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $14.51 | +17.16% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $9.33 | +425.19% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $101.83 | +33.56% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $90.00 | -22.22% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $154.96 | +74.24% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $78.08 | - | 2 | Nov 2, 2017 |
Minimed Group
Mar 31, 2026
Initiates: Overweight
Price Target: $26
Current: $13.23
Upside: +96.52%
HeartFlow
Mar 19, 2026
Maintains: Overweight
Price Target: $38 → $35
Current: $26.87
Upside: +30.26%
Anteris Technologies Global
Mar 11, 2026
Initiates: Overweight
Price Target: $16
Current: $5.32
Upside: +200.75%
Teleflex
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $116 → $130
Current: $115.51
Upside: +12.54%
Merit Medical Systems
Feb 26, 2026
Downgrades: Equal-Weight
Price Target: $95 → $78
Current: $67.40
Upside: +15.73%
Alcon
Feb 26, 2026
Upgrades: Overweight
Price Target: $88 → $97
Current: $74.67
Upside: +29.90%
Bausch + Lomb
Feb 19, 2026
Maintains: Equal-Weight
Price Target: $17 → $18
Current: $15.92
Upside: +13.07%
Axogen
Feb 19, 2026
Initiates: Overweight
Price Target: $40
Current: $30.99
Upside: +29.07%
Glaukos
Feb 18, 2026
Maintains: Overweight
Price Target: $122 → $135
Current: $115.06
Upside: +17.33%
DexCom
Feb 13, 2026
Maintains: Overweight
Price Target: $93 → $85
Current: $63.11
Upside: +34.69%
Feb 12, 2026
Downgrades: Equal-Weight
Price Target: $145 → $70
Current: $54.42
Upside: +28.63%
Feb 11, 2026
Maintains: Equal-Weight
Price Target: $93 → $98
Current: $91.40
Upside: +7.22%
Feb 11, 2026
Maintains: Overweight
Price Target: $96 → $100
Current: $80.84
Upside: +23.70%
Feb 5, 2026
Maintains: Overweight
Price Target: $95 → $97
Current: $69.73
Upside: +39.11%
Feb 5, 2026
Maintains: Overweight
Price Target: $125 → $94
Current: $61.86
Upside: +51.96%
Jan 22, 2026
Maintains: Overweight
Price Target: $230 → $240
Current: $238.41
Upside: +0.67%
Jan 15, 2026
Downgrades: Equal-Weight
Price Target: $374
Current: $329.96
Upside: +13.35%
Dec 12, 2025
Maintains: Overweight
Price Target: $27 → $28
Current: $19.49
Upside: +43.66%
Dec 5, 2025
Maintains: Equal-Weight
Price Target: $72 → $82
Current: $69.66
Upside: +17.71%
Nov 19, 2025
Maintains: Overweight
Price Target: $100 → $114
Current: $86.42
Upside: +31.91%
Nov 14, 2025
Maintains: Overweight
Price Target: $452 → $456
Current: $332.07
Upside: +37.32%
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $13 → $14
Current: $18.28
Upside: -23.41%
Nov 6, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $6.76
Upside: +47.93%
Oct 22, 2025
Maintains: Overweight
Price Target: $599 → $600
Current: $452.95
Upside: +32.46%
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.11
Upside: -23.42%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.28
Upside: +134.38%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $16.62
Upside: +44.40%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $10.35
Upside: +40.10%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $14.51
Upside: +17.16%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $9.33
Upside: +425.19%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $101.83
Upside: +33.56%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $90.00
Upside: -22.22%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $154.96
Upside: +74.24%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $78.08
Upside: -